Synchronous Bilateral Primary Male Breast Carcinoma with Hyperprolactinemia

Abstract

Male breast cancer represents approximately 1% of all breast cancer cases. Due to the low disease incidence, even the largest reported studies have included a limited number of cases. Therefore, there is a lack of extensive experience as far as the etiology, therapeutic modalities and prognosis of this disease are concerned.